Ameh Soter, Klipstein-Grobusch Kerstin, Musenge Eustasius, Kahn Kathleen, Tollman Stephen, Gómez-Olivé Francesc Xavier
*Medical Research Council/Wits University Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; †Department of Community Medicine, Faculty of Medicine, College of Medical Sciences, University of Calabar, Calabar, Nigeria; ‡Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; §Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; ‖The International Network for the Demographic Evaluation of Populations and Their Health in Developing Countries (INDEPTH), Accra, Ghana; and ¶Epidemiology and Global Health, Umeå Centre for Global Health Research,Umeå University, Umeå, Sweden.
J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):472-479. doi: 10.1097/QAI.0000000000001437.
South Africa faces a dual burden of HIV/AIDS and noncommunicable diseases. In 2011, a pilot integrated chronic disease management (ICDM) model was introduced by the National Health Department into selected primary health care (PHC) facilities. The objective of this study was to assess the effectiveness of the ICDM model in controlling patients' CD4 counts (>350 cells/mm) and blood pressure [BP (<140/90 mm Hg)] in PHC facilities in the Bushbuckridge municipality, South Africa.
A controlled interrupted time-series study was conducted using the data from patients' clinical records collected multiple times before and after the ICDM model was initiated in PHC facilities in Bushbuckridge. Patients ≥18 years were recruited by proportionate sampling from the pilot (n = 435) and comparing (n = 443) PHC facilities from 2011 to 2013. Health outcomes for patients were retrieved from facility records for 30 months. We performed controlled segmented regression to model the monthly averages of individuals' propensity scores using autoregressive moving average model at 5% significance level.
The pilot facilities had 6% greater likelihood of controlling patients' CD4 counts than the comparison facilities (coefficient = 0.057; 95% confidence interval: 0.056 to 0.058; P < 0.001). Compared with the comparison facilities, the pilot facilities had 1.0% greater likelihood of controlling patients' BP (coefficient = 0.010; 95% confidence interval: 0.003 to 0.016; P = 0.002).
Application of the model had a small effect in controlling patients' CD4 counts and BP, but showed no overall clinical benefit for the patients; hence, the need to more extensively leverage the HIV program for hypertension treatment.
南非面临着艾滋病毒/艾滋病和非传染性疾病的双重负担。2011年,国家卫生部在选定的初级卫生保健(PHC)机构引入了试点综合慢性病管理(ICDM)模式。本研究的目的是评估ICDM模式在南非布什布克里奇市初级卫生保健机构中控制患者CD4细胞计数(>350个细胞/mm³)和血压[收缩压/舒张压(<140/90 mmHg)]的有效性。
采用在布什布克里奇初级卫生保健机构启动ICDM模式之前和之后多次收集的患者临床记录数据进行对照中断时间序列研究。2011年至2013年,通过比例抽样从试点(n = 435)和对照(n = 443)初级卫生保健机构招募年龄≥18岁的患者。从机构记录中获取患者30个月的健康结果。我们使用自回归移动平均模型在5%显著性水平下进行对照分段回归,以模拟个体倾向得分的月平均值。
与对照机构相比,试点机构控制患者CD4细胞计数的可能性高6%(系数 = 0.057;95%置信区间:0.056至0.058;P < 0.001)。与对照机构相比,试点机构控制患者血压的可能性高1.0%(系数 = 0.010;95%置信区间:0.003至0.016;P = 0.002)。
该模式的应用在控制患者CD4细胞计数和血压方面有微小效果,但对患者未显示出总体临床益处;因此,需要更广泛地利用艾滋病毒项目进行高血压治疗。